| Literature DB >> 35597678 |
J Vila1, J Capsec2, M Bigoteau1, K Pommier1, A-R Cook1, P-J Pisella1, R K Khanna3.
Abstract
INTRODUCTION: At the beginning of the COVID-19 pandemic, the French government implemented its first national lockdown between March and May 2020 in order to limit the dissemination of the virus. This historic measure affected patients' daily lives and transportation, resulting in changes in the delivery of medical care, particularly emergency care. This study aimed to assess the impact of this restriction policy on the number and severity of ophthalmic emergencies seen in an ophthalmology emergency department.Entities:
Keywords: BaSe SCOrE; COVID-19; Confinement; Epidemiology; Lockdown; Ophthalmic emergencies; Pandemic; Pandémie; Urgences ophtalmologiques; Épidémiologie
Mesh:
Year: 2022 PMID: 35597678 PMCID: PMC9040442 DOI: 10.1016/j.jfo.2022.02.006
Source DB: PubMed Journal: J Fr Ophtalmol ISSN: 0181-5512 Impact factor: 1.194
Figure 1Flow chart.
Population characteristics (IQ1 and IQ3: Interquartile range 1 and 3).
| Lockdown 2019 | Lockdown 2020 | Post-lockdown 2019 | Post-lockdown 2020 | |
|---|---|---|---|---|
| Number of patients | 1905 | 1186 | 1242 | 1086 |
| Age (median, IQ1–IQ3) | 48 (32–65) | 50 (34–66) | 49 (31–67) | 49 (31–65) |
| Masculine gender ( | 1003 (52,7) | 671 (56,6) | 643 (51,8) | 581 (53,5) |
| Consultation time (in hours; mean ± standard deviation) | 14,1 (±3,7) | 13,8 (±3,6) | 14,3 (±3,9) | 14,1 (±3,9) |
| Working hours ( | 1352 (71,0) | 864 (72,8) | 861 (69,3) | 757 (69,7) |
| Delay between symptoms onset and consultation≤48 h ( | 803 (50,4) | 504 (52,7) | 508 (47,9) | 480 (52,1) |
| Severity according to BaSe SCOrE (n, %) | ||||
| 1 | 860 (45,1) | 517 (43,6) | 571 (46,0) | 514 (47,3) |
| 2 | 530 (27,8) | 347 (29,3) | 380 (30,6) | 295 (27,2) |
| 3 | 198 (10,4) | 168 (14,2) | 109 (8,8) | 100 (9,2) |
| 4 | 56 (2,9) | 47 (4,0) | 44 (3,5) | 40 (3,7) |
| 5 | 47 (2,5) | 28 (2,4) | 18 (1,4) | 19 (1,7) |
| Off score | 214 (11,2) | 79 (6,7) | 120 (9,7) | 118 (10,9) |
| Workplace injuries ( | 80 (15,6) | 31 (9,7) | 35 (10,3) | 55 (15,6) |
Reasons for consultation.
| Reasons ( | Lockdown 2019 | Lockdown 2020 | Post-lockdown 2019 | Post-lockdown 2020 |
|---|---|---|---|---|
| Trauma | 512 (27) | 319 (27) | 339 (27) | 344 (32) |
| Swelling, redness (eyelids, tear duct, orbit, conjunctivitis) | 321 (17) | 131 (11) | 229 (18) | 166 (15) |
| Surface discomfort/tearing | 272 (14) | 216 (18) | 177 (14) | 138 (13) |
| Pain | 265 (14) | 175 (15) | 160 (13) | 150 (14) |
| Permanent loss of visual acuity | 217 (11) | 138 (12) | 135 (11) | 117 (11) |
| Myodesopsia/photopsia | 149 (8) | 124 (1) | 91 (7) | 99 (9) |
| Headache | 35 (2) | 6 (1) | 13 (1) | 11 (1) |
| Ocular secretions | 30 (2) | 2 (<1) | 24 (2) | 3 (<1) |
| Abnormal eye movements | 22 (1) | 15 (1) | 12 (1) | 17 (2) |
| Veil/scotoma | 18 (1) | 12 (1) | 15 (1) | 3 (<1) |
| Assessment during systemic pathology check-up | 13 (1) | 6 (1) | 6 (<1) | 6 (1) |
| Transient visual impairment | 12 (1) | 16 (1) | 8 (1) | 16 (1) |
| Missing data | 9 (<1) | 1 (<1) | 1 (<1) | 2 (<1) |
| other | 9 (<1) | 4 (<1) | 10 (1) | 5 (<1) |
| Photophobia | 8 (<1) | 8 (1) | 7 (1) | 5 (<1) |
| Metamorphopsia | 6 (<1) | 6 (1) | 5 (<1) | 1 (<1) |
| Impaired visual field | 5 (<1) | 6 (1) | 9 (1) | 3 (<1) |
| Pupillary abnormality | 1 (<1) | 1 (<1) | 1 (<1) | 0 (<) |
| Visual hallucinations | 1 (<1) | 0 (<1) | 0 (<1) | 0 (<1) |
Distribution of diagnoses by specialities.
| Subspecialties | Diagnostics | Lockdown 2019 | Lockdown 2020 | Post-lockdown 2019 | Post-lockdown 2020 |
|---|---|---|---|---|---|
| Anterior segment | Conjunctivitis/subconjunctival haemorrhage (%) | 350 (18) | 151 (13) | 222 (18) | 156 (14) |
| Infectious, abscessed, immune-allergic, inflammatory keratitis (%) | 193 (10) | 126 (11) | 146 (12) | 138 (13) | |
| Conjunctival lesions (%) | 25 (1) | 10 (1) | 18 (1) | 13 (1) | |
| Corneal dystrophy/degeneration (%) | 5 (<1) | 4 (<1) | 8 (1) | 5 (<1) | |
| Trauma | Trauma with extra ocular foreign body (%) | 257 (13) | 212 (18) | 169 (14) | 177 (16) |
| Trauma without foreign body (%) | 246 (13) | 190 (16) | 176 (14) | 158 (15) | |
| Eyelid wound/tear duct wound/foreign body in the eyelid (%) | 7 (<1) | 1 (<1) | 2 (<1) | 4 (<1) | |
| Orbital fracture (%) | 5 (<1) | 0 (<1) | 1 (<1) | 2 (<1) | |
| Intraocular foreign body (%) | 3 (<1) | 0 (<1) | 0(<1) | 2 (<1) | |
| Ocular globe wound (%) | 1 (<1) | 3 (<1) | 3 (<1) | 2 (<1) | |
| Posterior segment | Floating bodies/PVD (%) | 112 (6) | 91 (8) | 75 (6) | 76 (7) |
| Vascular or neovascular retinochoroidopathy group (%) | 53 (3) | 34 (3) | 21 (2) | 25 (2) | |
| Retinal detachment/vitreo-macular traction/macular hole (%) | 42 (2) | 18 (2) | 20 (2) | 15 (1) | |
| Intravitreal haemorrhage (%) | 16 (1) | 16 (1) | 16 (1) | 10 (1) | |
| Retinal tear (%) | 15 (1) | 14 (1) | 8 (1) | 9 (1) | |
| Rupture in Bruch membrane in high myopia (%) | 3 (<1) | 1 (<1) | 1 (<1) | 0 (<1) | |
| Posterior segment tumour (%) | 1 (<1) | 0 (<1) | 2 (<1) | 0 (<1) | |
| Eyelid and orbital disorders | Dermohypoderma of the face/dacryoadenitis (%) | 17 (1) | 14 (1) | 10 (1) | 6 (1) |
| Various orbitopathies (%) | 5 (<1) | 2 (<1) | 2 (<1) | 1 (<1) | |
| Eyelid tumour or malposition (%) | 5 (<1) | 11 (1) | 4 (<1) | 4 (<1) | |
| Dacryocele/tear duct stenosis/tear perforation (%) | 2 (<1) | 2 (<1) | 3 (<1) | 1 (<1) | |
| Eye inflammation | Uveitis/scleritis/episcleritis (%) | 76 (4) | 56 (5) | 52 (4) | 49 (5) |
| Neuro-ophthalmology | Migraine (%) | 26 (1) | 20 (2) | 23 (2) | 10 (1) |
| Diplopia, oculomotor paralysis and supra-nuclear damage (%) | 19 (1) | 15 (1) | 8 (1) | 13 (1) | |
| Transient monocular blindness/stroke/TIA/focal neurological injury (%) | 10 (1) | 9 (1) | 6 (<1) | 6 (1) | |
| Optic neuropathy (%) | 9 (<1) | 8 (1) | 4 (<1) | 5 (<1) | |
| Pupil pathology (%) | 4 (<1) | 0 (<1) | 2 (<1) | 0 (<1) | |
| Idiopathic/secondary ICH (%) | 2 (<1) | 2 (<1) | 0 (<1) | 1 (<1) | |
| Retrochiasmatic visual pathway damage (%) | 2 (<1) | 0 (<1) | 1 (<1) | 0 (<1) | |
| Post-operative complications | Post-operative complication (%) | 66 (3) | 39 (3) | 50 (4) | 19 (2) |
| Intraocular hypertonia | NVG, AACG and acute ocular hypertonia excluding AACG and NVG (%) | 10 (1) | 8 (1) | 6 (<1) | 8 (1) |
| Iatrogenic event | Drug-related iatrogeny (%) | 9 (<1) | 2 (<1) | 4 (<1) | 1 (<1) |
| Normal examination | Normal examination (%) | 98 (5) | 29 (2) | 50 (4) | 64 (6) |
| Other | - | 64 (3) | 40 (3) | 36 (3) | 40 (4) |
| Missing data | Missing data (%) | 0 (<1) | 2 (<1) | 0 (<1) | 1 (<1) |
Figure 2Number of weekly ophthalmic emergencies in 2019 and 2020.
Figure 3Histogram of the distribution of severity scores by time period.